{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:18:54Z","timestamp":1771553934787,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,21]]},"DOI":"10.7759\/cureus.52684","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T03:43:27Z","timestamp":1705895007000},"source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Angiotensin-Converting Enzyme Inhibitors in Coronary Microvascular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials"],"prefix":"10.7759","author":[{"given":"Mohamed R","family":"Abouzid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Eldahtoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shorouk M","family":"Elshafei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaf","family":"Esteghamati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti VR","year":"2018","unstructured":"Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol. 2018, 72:2625-41. 10.1016\/j.jacc.2018.09.042","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.07.011","article-title":"In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women\u2019s ischemia syndrome evaluation (WISE)","volume":"162","author":"Pauly DF","year":"2011","unstructured":"Pauly DF, Johnson BD, Anderson RD, et al.. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women\u2019s ischemia syndrome evaluation (WISE). Am Heart J. 2011, 162:678-84. 10.1016\/j.ahj.2011.07.011","journal-title":"Am Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.114198","article-title":"Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study","volume":"141","author":"Reis SE","year":"2001","unstructured":"Reis SE, Holubkov R, Conrad Smith AJ, et al.. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001, 141:735-41. 10.1067\/mhj.2001.114198","journal-title":"Am Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.11.015","article-title":"High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. the ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries)","volume":"59","author":"Ong P","year":"2012","unstructured":"Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. the ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012, 59:655-62. 10.1016\/j.jacc.2011.11.015","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00421-X","article-title":"Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X","volume":"31","author":"Pasceri V","year":"1998","unstructured":"Pasceri V, Lanza GA, Buffon A, et al.. Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. J Am Coll Cardiol. 1998, 31:62-66. 10.1016\/S0735-1097(97)00421-X","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.96.3.821","article-title":"Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy","volume":"96","author":"Lanza GA","year":"1997","unstructured":"Lanza GA, Giordano A, Pristipino C, et al.. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation. 1997, 96:821-6. 10.1161\/01.cir.96.3.821","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular\u00a0angina, and treatment strategies","volume":"8","author":"Marinescu MA","year":"2015","unstructured":"Marinescu MA, L\u00f6ffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM. Coronary microvascular dysfunction, microvascular\u00a0angina, and treatment strategies. JACC Cardiovasc Imaging. 2015, 8:210-20. 10.1016\/j.jcmg.2014.12.008","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.09.081","article-title":"Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: women\u2019s ischemia syndrome evaluation-coronary vascular dysfunction ancillary study","volume":"276","author":"Rambarat CA","year":"2019","unstructured":"Rambarat CA, Elgendy IY, Handberg EM, et al.. Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: women\u2019s ischemia syndrome evaluation-coronary vascular dysfunction ancillary study. Int J Cardiol. 2019, 276:8-13. 10.1016\/j.ijcard.2018.09.081","journal-title":"Int J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease","volume":"138","author":"Kaski JC","year":"2018","unstructured":"Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of ischemic heart disease. Circulation. 2018, 138:1463-80. 10.1161\/CIRCULATIONAHA.118.031373","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.9.948","article-title":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction","volume":"101","author":"Suwaidi JA","year":"2000","unstructured":"Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000, 101:948-54. 10.1161\/01.cir.101.9.948","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.081828","article-title":"Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging","volume":"52","author":"Fukushima K","year":"2011","unstructured":"Fukushima K, Javadi MS, Higuchi T, Lautam\u00e4ki R, Merrill J, Nekolla SG, Bengel FM. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med. 2011, 52:726-32. 10.2967\/jnumed.110.081828","journal-title":"J Nucl Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011939","article-title":"Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization","volume":"131","author":"Taqueti VR","year":"2015","unstructured":"Taqueti VR, Hachamovitch R, Murthy VL, et al.. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015, 131:19-27. 10.1161\/CIRCULATIONAHA.114.011939","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.120402","article-title":"Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus","volume":"126","author":"Murthy VL","year":"2012","unstructured":"Murthy VL, Naya M, Foster CR, et al.. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012, 126:1858-68. 10.1161\/CIRCULATIONAHA.112.120402","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.580419","article-title":"Effects of oral drugs on coronary microvascular function in patients without significant stenosis of epicardial coronary arteries: a systematic review and meta-analysis of coronary flow reserve","volume":"7","author":"Yong J","year":"2020","unstructured":"Yong J, Tian J, Yang X, Xing H, He Y, Song X. Effects of oral drugs on coronary microvascular function in patients without significant stenosis of epicardial coronary arteries: a systematic review and meta-analysis of coronary flow reserve. Front Cardiovasc Med. 2020, 7:580419. 10.3389\/fcvm.2020.580419","journal-title":"Front Cardiovasc Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa006","article-title":"Treatment of coronary microvascular dysfunction","volume":"116","author":"Bairey Merz CN","year":"2020","unstructured":"Bairey Merz CN, Pepine CJ, Shimokawa H, Berry C. Treatment of coronary microvascular dysfunction. Cardiovasc Res. 2020, 116:856-70. 10.1093\/cvr\/cvaa006","journal-title":"Cardiovasc Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6080258","article-title":"Updates on pharmacologic management of microvascular angina","volume":"2022","author":"Soleymani M","year":"2022","unstructured":"Soleymani M, Masoudkabir F, Shabani M, Vasheghani-Farahani A, Behnoush AH, Khalaji A. Updates on pharmacologic management of microvascular angina. Cardiovasc Ther. 2022, 2022:6080258. 10.1155\/2022\/6080258","journal-title":"Cardiovasc Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger M","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315:629-34. 10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90750-1","article-title":"Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina","volume":"23","author":"Kaski JC","year":"1994","unstructured":"Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol. 1994, 23:652-7. 10.1016\/0735-1097(94)90750-1","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196962","article-title":"Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: a randomized placebo-controlled trial","volume":"13","author":"Michelsen MM","year":"2018","unstructured":"Michelsen MM, Rask AB, Suhrs E, et al.. Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: a randomized placebo-controlled trial. PloS one. 2018, 13:0196962. 10.1371\/journal.pone.0196962","journal-title":"PloS one"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000001144","article-title":"Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study","volume":"22","author":"De Gregorio MG","year":"2021","unstructured":"De Gregorio MG, Fumagalli C, Tomberli A, et al.. Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study. J Cardiovasc Med (Hagerstown). 2021, 22:511-3. 10.2459\/JCM.0000000000001144","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000006768","article-title":"Therapeutic benefits of cilazapril in patients with syndrome X","volume":"89","author":"Nalbantgil I","year":"1998","unstructured":"Nalbantgil I, Onder R, Altintig A, Nalbantgil S, Kili\u00e7cioglu B, Boydak B, Yilmaz H. Therapeutic benefits of cilazapril in patients with syndrome X. Cardiology. 1998, 89:130-3. 10.1159\/000006768","journal-title":"Cardiology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000100722.34034.E4","article-title":"Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity","volume":"109","author":"Pizzi C","year":"2004","unstructured":"Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation. 2004, 109:53-8. 10.1161\/01.CIR.0000100722.34034.E4","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.11.025","article-title":"Intracoronary EnalaPrilat to reduce MICROvascular damage during percutaneous coronary intervention (ProMicro) study","volume":"61","author":"Mangiacapra F","year":"2013","unstructured":"Mangiacapra F, Peace AJ, Di Serafino L, et al.. Intracoronary EnalaPrilat to reduce MICROvascular damage during percutaneous coronary intervention (ProMicro) study. J Am Coll Cardiol. 2013, 61:615-21. 10.1016\/j.jacc.2012.11.025","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(02)02664-4","article-title":"Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function","volume":"90","author":"Chen","year":"2002","unstructured":"Chen, J. W., Hsu, et al.. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function. Am J Cardiol. 2002, 90:974-982. 10.1016\/s0002-9149(02)02664-4","journal-title":"Am J Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.27.5.1031","article-title":"Improvement of coronary flow reserve after long-term therapy with enalapril","volume":"27","author":"Motz W","year":"1996","unstructured":"Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension. 1996, 27:1031-8. 10.1161\/01.hyp.27.5.1031","journal-title":"Hypertension"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-6363(01)00457-6","article-title":"The pathophysiology of cardiac syndrome X--a tale of paradigm shifts","volume":"52","author":"Rosen SD","year":"2001","unstructured":"Rosen SD. The pathophysiology of cardiac syndrome X--a tale of paradigm shifts. Cardiovasc Res. 2001, 52:174-7. 10.1016\/s0008-6363(01)00457-6","journal-title":"Cardiovasc Res"},{"key":"ref27","article-title":"Cardiac Syndrome X","author":"Mahtani AU","year":"2023","unstructured":"Mahtani AU, Padda IS and Johal GS. Cardiac Syndrome X. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.11.1233","article-title":"Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function","volume":"102","author":"Kaufmann PA","year":"2000","unstructured":"Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Sch\u00e4fers KP, L\u00fcscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation. 2000, 102:1233-8. 10.1161\/01.cir.102.11.1233","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.12.3232","article-title":"Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis","volume":"94","author":"Yokoyama I","year":"1996","unstructured":"Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 1996, 94:3232-8. 10.1161\/01.cir.94.12.3232","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.87.1.86","article-title":"Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels","volume":"87","author":"Treasure CB","year":"1993","unstructured":"Treasure CB, Klein JL, Vita JA, et al.. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993, 87:86-93. 10.1161\/01.cir.87.1.86","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00327-6","article-title":"Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus","volume":"30","author":"Yokoyama I","year":"1997","unstructured":"Yokoyama I, Momomura S, Ohtake T, et al.. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1997, 30:1472-7. 10.1016\/s0735-1097(97)00327-6","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp205","article-title":"Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease","volume":"30","author":"Recio-Mayoral A","year":"2009","unstructured":"Recio-Mayoral A, Mason JC, Kaski JC, Rubens MB, Harari OA, Camici PG. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J. 2009, 30:1837-43. 10.1093\/eurheartj\/ehp205","journal-title":"Eur Heart J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-015-0682-9","article-title":"Coronary microvascular dysfunction, microvascular angina, and management","volume":"18","author":"L\u00f6ffler AI","year":"2016","unstructured":"L\u00f6ffler AI, Bourque JM. Coronary microvascular dysfunction, microvascular angina, and management. Curr Cardiol Rep. 2016, 18:1. 10.1007\/s11886-015-0682-9","journal-title":"Curr Cardiol Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(74)93260-7","article-title":"Angina pectoris with normal coronary arteries. transvenous myocardial biopsy in diagnosis","volume":"2","author":"Richardson PJ","year":"1974","unstructured":"Richardson PJ, Livesley B, Oram S, et al.. Angina pectoris with normal coronary arteries. transvenous myocardial biopsy in diagnosis. Lancet. 1974, 2:677-80. 10.1016\/s0140-6736(74)93260-7","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici PG","year":"2007","unstructured":"Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007, 356:830-40. 10.1056\/NEJMra061889","journal-title":"N Engl J Med"},{"key":"ref36","article-title":"Myocardial blood flow measurement by PET: technical aspects and clinical applications","volume":"46","author":"Kaufmann PA","year":"2005","unstructured":"Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med. 2005, 46:75-88.","journal-title":"J Nucl Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90347-r","article-title":"Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries","volume":"16","author":"Geltman EM","year":"1990","unstructured":"Geltman EM, Henes CG, Senneff MJ, et al.. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol. 1990, 16:586-95. 10.1016\/0735-1097(90)90347-r","journal-title":"J Am Coll Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve","volume":"124","author":"Murthy VL","year":"2011","unstructured":"Murthy VL, Naya M, Foster CR, et al.. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011, 124:2215-24. 10.1161\/CIRCULATIONAHA.111.050427","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.96.10.3369","article-title":"Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe)","volume":"96","author":"Serruys PW","year":"1997","unstructured":"Serruys PW, di Mario C, Piek J, et al.. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation. 1997, 96:3369-77. 10.1161\/01.cir.96.10.3369","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine CJ","year":"2010","unstructured":"Pepine CJ, Anderson RD, Sharaf BL, et al.. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010, 55:2825-32. 10.1016\/j.jacc.2010.01.054","journal-title":"J Am Coll Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea F","year":"2014","unstructured":"Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014, 35:1101-11. 10.1093\/eurheartj\/eht513","journal-title":"Eur Heart J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00181.2007","article-title":"Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation","volume":"293","author":"Banes-Berceli AK","year":"2007","unstructured":"Banes-Berceli AK, Ketsawatsomkron P, Ogbi S, Patel B, Pollock DM, Marrero MB. Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. Am J Physiol Heart Circ Physiol. 2007, 293:H1291-9. 10.1152\/ajpheart.00181.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.37.4.1047","article-title":"Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis","volume":"37","author":"Dzau VJ","year":"2001","unstructured":"Dzau VJ. Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001, 37:1047-52. 10.1161\/01.hyp.37.4.1047","journal-title":"Hypertension"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston M","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019, 10:ED000142. 10.1002\/14651858.ED000142","journal-title":"Cochrane Database Syst Rev"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2020.09.005","article-title":"Efficacy of ranolazine for treatment of coronary microvascular dysfunction-a systematic review and meta-analysis of randomized trials","volume":"3","author":"Kofler T","year":"2021","unstructured":"Kofler T, Hess S, Moccetti F, et al.. Efficacy of ranolazine for treatment of coronary microvascular dysfunction-a systematic review and meta-analysis of randomized trials. CJC Open. 2021, 3:101-8. 10.1016\/j.cjco.2020.09.005","journal-title":"CJC Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/205507-efficacy-of-angiotensin-converting-enzyme-inhibitors-in-coronary-microvascular-dysfunction-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:40Z","timestamp":1707509620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/205507-efficacy-of-angiotensin-converting-enzyme-inhibitors-in-coronary-microvascular-dysfunction-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.52684","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,21]]}}}